Prevalence of anti-HCV antibodies in adult patient population of primary care clinic in Warsaw

• Authors: Boguradzka Anna , Mazurczak-Pluta Teresa , Rzewuska Dorota , Ptasiński Adam
• Languages of publication: EN

Keywords

EN

anti-HCV antibodies; primary health care; risk factor

• Publisher: Stowarzyszenie Przyjaciół Medycyny Rodzinnej i Lekarzy Rodzinnych
• Journal: Family Medicine & Primary Care Review
• Year: 2012
• Issue: 4
• Pages: 555-558

Contributors

author

Boguradzka Anna

author

Mazurczak-Pluta Teresa

author

Rzewuska Dorota

author

Ptasiński Adam

References

• Muhlberger N, Schwarzer 1. R, Lettmeier B, et al. HCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity and mortality. BMC Public Health 2009; 9: 34.
• Szczeklik A, Gajewski P. Choroby wewnętrzne. Kompendium medycyny praktycznej. Kraków: Medycyna Praktyczna;2009: 520–523
• Yamada T. Podręcznik gastroenterologii. Lublin: Wydawnictwo Czelej; 2006: 614–617.
• McGinn T, O’Connor-Moore N, Alfandre D, et al. Validation of Hepatitis C screening tool in primary care. Inter Med 2008; 168(18): 2009–2013.
• Lee MH, Yang HI, Jen CL, et al. Community and personal risk factors for hepatitis C virus infection: a survey of 23 820 residents in Taiwan in 1991–92. GUT 2011; 60(5): 688–694.
• Evaluation of acute hepatitis C infection surveillance in United States, 2008. MMWR Morb Mortal Wkly Rep 2010 Nov.5; 59(43): 1407–1410.
• Paralicová Z, Kristian P, Schréter I. Epidemiological survey of hepatitis C at the Clinic of Infectology and Travel Medicine in Kosice. Epidemiol Mikrobiol Imunol 2010; 59(4): 158–162.
• Nguyen NH, Vutien P, Trinh HN, et al. Risk factors, genotype 6 prevalence, and clinical characteristics of chronic hepatitis C in Southeast Asian Americans. Hepatol Int 2010 Apr. 9; 4(2): 523–529.
• Suzuki T. A Hepatitis C virus-host interaction involved in viral replication: toward the identification of antiviral targets.Jpn J Infect Dis 2010; 63(5): 307–311.
• Méndez-Sánchez N, Gutiérrez-Grobe Y, Kobashi-Margáin RA. Epidemiology of HCV infection in Latin America. Ann Hepatol 2010; 9 Suppl: 27–29.
• Stepień M, Rosińska M. Hepatitis C in Poland in 2008. Przegl Epidemiol 2010; 64(2): 245–250.
• Elasifer HA, Agnnyia YM, Al-Alagi BA. Epidemiological manifestations of hepatitis C virus genotypes and its association with potential risk factors among Libyan patients. Virol J 2010 Nov. 13; 7: 317.
• Gadano A, Galdame O, Marciano S. Diagnosis of patients with suspected chronic hepatitis C infection. Ann Hepatol 2010; 9 Suppl: 34–38.
• Pépin J, Lavoie M, Pybus OG, et al. Risk factors for hepatitis C virus transmission in colonial Cameroon. Clin Infect Dis 2010 Oct. 1; 51(7): 768–776.
• Europejskie Centrum Monitorowania Narkotyków i Narkomanii. Sprawozdanie Roczne 2009. Stan problemu narkotykowego w Europie. Luksemburg: Urząd Publikacji Unii Europejskiej; 2009: 70–92.
• Albeldawi M, Ruiz-Rodriguez E, Carey WD. Hepatitis C virus: prevention, screening, and interpretation of assays.Cleve Clin J Med 2010 Sep; 77(9): 616–626